Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort
Amedeo Minichino, Matthew Jackson, Marta Francesconi, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6269-6276
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The gut microbiome and mental health: advances in research and emerging priorities
Andrew Shoubridge, Jocelyn M. Choo, Alyce M. Martin, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1908-1919
Closed Access | Times Cited: 80
Psycho-Pharmacomicrobiomics: A Systematic Review and Meta-Analysis
Amedeo Minichino, Tabitha Preston, Jack B. Fanshawe, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 7, pp. 611-628
Open Access | Times Cited: 23
Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
Claudio Pirozzi, Lorena Coretti, Nicola Opallo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 22
Remodeling of microbiota gut-brain axis using psychobiotics in depression
Mani Surya Kumar Palepu, Manoj P. Dandekar
European Journal of Pharmacology (2022) Vol. 931, pp. 175171-175171
Closed Access | Times Cited: 32
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids
Iddrisu Ibrahim, Soumyakrishnan Syamala, Joseph Ayariga, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1247-1247
Open Access | Times Cited: 30
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Stuart M. Brierley, Beverley Greenwood‐Van Meerveld, Giovanni Sarnelli, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 5-25
Closed Access | Times Cited: 25
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Congchong Wu, Qingli Mu, Weijia Gao, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective
Yang Wang, Jiafu Ji, Zhuqing Mao, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
Muthanna Sultan, Kiesha Wilson, Osama A. Abdulla, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3305-3305
Open Access | Times Cited: 29
Effects of Non-Polar Dietary and Endogenous Lipids on Gut Microbiota Alterations: The Role of Lipidomics
Konstantinos Tsiantas, Spyridon J. Konteles, Eftichia Kritsi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4070-4070
Open Access | Times Cited: 19
Gut Microbiome-Based Diagnostic Model to Predict Diabetes Mellitus
Haitao Yang, Jing‐Kun Liu, Wen‐Juan Xiu, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12521-12534
Open Access | Times Cited: 26
Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice With Cognitive Dysfunction Induced by Chronic Neuropathic Pain
Dongyu Hua, Shan Li, Shiyong Li, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
Antonio Inserra, Giada Giorgini, Sébastien Lacroix, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 6, pp. 721-739
Closed Access | Times Cited: 17
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Hayatte-Dounia Mir, Giada Giorgini, Vincenzo Di Marzo
Psychoneuroendocrinology (2023) Vol. 154, pp. 106295-106295
Closed Access | Times Cited: 10
Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint
Aniello Schiano Moriello, Vincenzo Di Marzo, Stefania Petrosino
Animals (2022) Vol. 12, Iss. 3, pp. 348-348
Open Access | Times Cited: 15
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
Riccardo Bortoletto, Fabiana Piscitelli, Anna Candolo, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFκB-NLRP2-Caspase1-IL1β pathway
Zheng‐Meng Jiang, Fangfang Wang, Yuanyuan Zhao, et al.
Phytomedicine (2024) Vol. 132, pp. 155847-155847
Closed Access | Times Cited: 2
Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
Cheolmin Shin, Yong‐Ku Kim
Advances in experimental medicine and biology (2023), pp. 17-37
Closed Access | Times Cited: 6
Gut bacteria, endocannabinoid system, and marijuana addiction: Novel therapeutic implications
Kishore Kumar Pinapati, Sree Vidya, Faiz Khan, et al.
Health Sciences Review (2023) Vol. 10, pp. 100144-100144
Open Access | Times Cited: 6
The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
Tiziana Bisogno, Anna Lauritano, Fabiana Piscitelli
Life (2021) Vol. 11, Iss. 9, pp. 934-934
Open Access | Times Cited: 13
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults
Riccardo Bortoletto, Marta Basaldella, Anna Candolo, et al.
Clinical and Translational Neuroscience (2024) Vol. 8, Iss. 2, pp. 20-20
Open Access | Times Cited: 1
What's GABA got to do with it? A potential link between the microbiome, schizophrenia, and the endo-cannabinoid system
Ayala Glinert, Vladimir Zlidennyy, Sondra Turjeman, et al.
Psychiatry Research (2024) Vol. 342, pp. 116196-116196
Closed Access | Times Cited: 1
Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review
May Soe Thu, Barry J. Campbell, Nattiya Hirankarn, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117764-117764
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top